GLAB — Gemina Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Gemina Laboratories, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.

	2021 January 31st	2022 January 31st	2023 January 31st	2024 January 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.898	1.17	0.083	0.001
Net Total Accounts Receivable
Net Total Receivables	0.004	0.178	0.386	0.038
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2.45	1.38	0.563	0.093
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.046	0.041	0.318	0.369
Long Term Investments
Other Long Term Assets
Total Assets	2.53	1.42	1.87	1.46
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.33	0.47	1.75	2.84
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	2.37	0.476	1.95	3.04
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.16	0.944	-0.072	-1.59
Total Liabilities & Shareholders' Equity	2.53	1.42	1.87	1.46
Total Common Shares Outstanding